+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

Peanut Allergy Treatment Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Peanut Allergy Treatment Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Atopic Dermatitis Drugs - Global Strategic Business Report - Product Thumbnail Image

Atopic Dermatitis Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 179 Pages
  • Global
From
Gastrointestinal Endoscopy Market Report 2025 - Product Thumbnail Image

Gastrointestinal Endoscopy Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Renal cell carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Renal cell carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Ocular Drug Delivery Market Report 2025 - Product Thumbnail Image

Ocular Drug Delivery Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Allergy Treatment Market Report 2025 - Product Thumbnail Image

Allergy Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Loading Indicator